The PRS captures prognostic heterogeneity and distinct immune microenvironment features in DLBCL and may provide a useful tool for risk stratification, and CEACAM3 may serve as a potential biomarker and therapeutic target in DLBCL.
Abstract
Background Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma and remains highly heterogeneous in prognosis. Palmitoylation, an important post-translational modification, has been implicated in tumor biology, but its role in DLBCL, particularly in relation to the immune microenvironment, remains unclear. Methods Transcriptomic and clinical data from 706 patients with DLBCL were obtained from the Gene Expression Omnibus database. Prognosis-associated palmitoylation-related genes were identified by differential expression and univariate Cox regression analyses. An optimal prognostic model was developed by comparing 101 machine learning algorithm combinations and was further integrated with clinical variables to construct a nomogram. The tumor immune microenvironment was evaluated using immune infiltration, immune function, immune checkpoint, and Tumor Immune Dysfunction and Exclusion analyses. Weighted gene co-expression network analysis (WGCNA) and Mendelian randomization (MR) were performed to identify key genes, followed by experimental validation. Results A 33-gene palmitoylation-related signature (PRS) was established and evaluated across multiple cohorts. PRS was an independent prognostic factor of DLBCL and showed consistent prognostic performance across datasets. Low-risk patients showed higher immune cell infiltration and more active immune function, whereas high-risk patients showed a greater predicted potential to respond to immune checkpoint inhibitor therapy. A nomogram integrating PRS with clinical characteristics also showed favorable predictive accuracy. In addition, two palmitoylation-related molecular subtypes with distinct transcriptomic features, survival outcomes, and immune microenvironment characteristics were identified in DLBCL. CEACAM3 was prioritized as a key candidate gene based on integrated WGCNA and MR analyses, and functional experiments showed that CEACAM3 knockdown suppressed proliferation and invasion and promoted apoptosis, whereas CEACAM3 overexpression enhanced proliferation and invasion, reduced apoptosis, and promoted tumor growth. Conclusion The PRS captures prognostic heterogeneity and distinct immune microenvironment features in DLBCL. PRS may provide a useful tool for risk stratification, and CEACAM3 may serve as a potential biomarker and therapeutic target in DLBCL.
The SERPINE1/CTHRC1/EGR1 signature provides prognostic and immune-stromal information in GC, and the experiments support a tumor-promoting role for CTHRC1, which defines a palmitoylation-associated transcriptional framework but do not establish a palmitoylation-dependent mechanism.
Hong-Mei Sheng, Xue-Jun Li, Chen Zhang et al.· Frontiers in Immunology· 0 citations
The five‑gene palmitoylation‑associated prognostic model effectively stratifies AML patients by risk, reflects immune microenvironment dysregulation, and offers potential guidance for personalized therapy.
High-grade (FIGO Grade 3) uterine corpus endometrial carcinoma (UCEC) is an aggressive malignancy with limited therapeutic options and a poor prognosis. While ferroptosis is implicated in various cancers, its specific role within the tumor immune microenvironment of high-grade UCEC remains unclear.
We anal...
Yu Chen, Xi-Die Li, Yi-Fan Li et al.· World Journal of Surgical On...· 0 citations
IntroductionPANoptosis is an inflammatory form of programmed cell death integrating pyroptosis, apoptosis, and necroptosis, but its prognostic and immunological significance in clear cell renal cell carcinoma (ccRCC) remains unclear.MethodsIn this retrospective study, candidate PANoptosis-related genes (candidate PRGs)...
Xiao-Jing Wang, Yan Shen, Si-Ling Du et al.· Technology in Cancer Researc...· 0 citations
Background Gastric cancer (GC) is a molecularly heterogeneous disease. This study aims to explore whether endocytosis pathway-associated genes and immune checkpoint-related features were linked to GC subtypes and prognosis. Methods Public transcriptomic datasets from TCGA and GEO were analyzed. ssGSEA was applied to pr...
Guang-Yu Ding, Chen-Jie Xu, Xing-Mao Huang et al.· Frontiers in Oncology· 0 citations
These findings identify eight MP-related hub genes as candidate prognostic biomarkers and provide a risk model with acceptable predictive performance, offering insights into the immune-metabolic interplay in MM and suggesting potential avenues for personalized therapeutic strategies.
Ran Wang, Jing-Wei Zhang, Jing Qi et al.· Journal of Visualized Experi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.